مشاركة
مستوى هرمون الليبتين في مصل النساء المصابات بمتلازمة تكيس المبايض قبل وبعد العلاج بالميتفورمين == Serum Leptin Level In Women With Polycystic Ovary Syndrome Before And After Treatment With Metformin
اسم المؤلف:
بتول حسين كاظم
اسم المشرف:
وليد حميد يوسف سندال النصيري
الموضوع العام:
علوم الحياة
السنة:
2012
الموضوع الدقيق:
التقنيات الاحيائية
الدرجة:
دبلوم عالي
الجامعة:
جامعة النهرين - المعهد العالي لتشخيص العقم والتقنيات المساعدة على الانجاب
اللغة:
الانكليزية
مكان الجامعة:
بغداد
الصفحات الاولى:
24T2906 - p.pdf
المستخلص:
Polycystic ovary syndrome is the most common endocrinopathy in women, affecting 5 - 10% of women of reproductive age.The principal features of PCOS are anovulation, resulting in irregular menstruation, amenorrhea, ovulation - related infertility, and polycystic ovaries; excessive amounts or effects of androgenic hormones. Leptin, a key hormone in energy homeostasis and neuroendocrine function, has a permissive role in the pathogenesis of reproductive dysfunction. Aim of the study To assess the role of serum leptin in women with PCOS and to evaluate leptin levels in PCOS women before and after treatment with metformin. Materials and Methods This prospective experimental study included 60 women of reproductive age (18 - 38years) were allocated to four groups : 15 obese women with PCOS (BMI >30 kg/m2), 15obese controls, 15 non - obese women with PCOS (BMI 18 - 30 kg/m2), and 15 non - obese controls. Serum leptin and insulin levels were measured and compared between case and control subjects also comparison done before and after treatment with metformin. Results There was a significant increase in leptin in non - obese PCOS group (8.2±2.73) compared to non - obese control (5.64±1.43), (P value=0.0032), insulin level was significantly higher in PCOS group (15.87±6.65) than control (5.47±1.68), (P value<0.001). There was significant decrease in BMI, leptin and insulin levels after 12 weeks of metformin treatment in obese and non - obese PCOS subjects. Conclusions Leptin level increased remarkably with increasing body weight. It is higher in non - obese PCOS women in comparison with non - obese healthy women. Treatment with metformin for 12 weeks resulted in significant reduction in leptin levels in both obese and non - obese PCOS subjects.
